Skip to main content
2024 Guide to Patient Support Services

MacroGenics

2024 PSS Guide

Macrogenics’ Margenza Access Support

MacroGenics offers the Margenza Access Support program to assist patients and their healthcare providers with access to Margenza (Table). Healthcare providers and prescribers can call 844-MED-MGNX (844-633-6469) to speak with a case manager who can assist with ordering information, reimbursement support, information on the Patient Assistance Program and Copay Assistance Program, and benefit investigations.

Margenza Access Support

By enrolling in Margenza Access Support, patients may receive various forms of support and information to help access Margenza, including insurance verification/prior authorization/appeals support, copay assistance, and other financial support.

Copay Assistance Program

Eligibility criteria for the Copay Assistance Program will apply.

To enroll your patient, complete the application at Margenza.com and fax to 844-256-5226.

Patient Assistance Program

Margenza Access Support offers a Patient Assistance Program to help qualifying patients obtain Margenza at no cost.

To enroll your patient, complete the application at Margenza.com and fax to 844-256-5226.

TABLE MacroGenics Oncology Drug

Drug
Indication
Patient support programs

Drug
Margenza (margetuximab-cmkb)
Indication
In combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have received 2 or more prior anti-HER2 regimens, at least 1 of which was for metastatic disease
Patient support programs